Home > Insider Trading > Filing (0001209191-15-070557)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1516479	Insys Therapeutics Inc.	INSY	Pharmaceutical Preparations (2834)	510327886

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
938296	H Theodore Stanley	C/O Insys Therapeutics, Inc. 444 South Ellis Street Chandler AZ 85224		Yes	No	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2015-09-10	2,000	$3.63	4,000	No	4	M	Direct
Common Stock	Disposition	2015-09-10	1,300	$36.00	2,700	No	4	S	Direct
Common Stock	Disposition	2015-09-10	700	$36.01	2,000	No	4	S	Direct
Common Stock	Acquisiton	2015-09-14	2,000	$3.63	4,000	No	4	M	Direct
Common Stock	Disposition	2015-09-14	2,000	$38.08	2,000	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	M	Direct
No	4	S	Direct
No	4	S	Direct
No	4	M	Direct
No	4	S	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Stock Option (right to buy)	Disposition	2015-09-10	2,000	$0.00	2,000	$3.63
Common Stock	Stock Option (right to buy)	Disposition	2015-09-14	2,000	$0.00	2,000	$3.63

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
38,000		2023-05-13	No	4	M	Direct
36,000		2023-05-13	No	4	M	Direct

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	6,000	Indirect	by non-profit corporation
Common Stock	10,200	Indirect	by limited partnership

Footnotes

On June 5, 2015, the Issuer effected a 2-for-1 forward stock split pursuant to a stock dividend, resulting in the reporting person's ownership of 1,000 additional shares.
The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $37.03 to $37.17 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
On June 5, 2015, the Issuer effected a 2-for-1 forward stock split pursuant to a stock dividend, resulting in the reporting person's ownership of 3,000 additional shares.
The Reporting Person disclaims beneficial ownership of the Securities except to the extent of his pecuriniary interest therein.
On June 5, 2015, the Issuer effected a 2-for-1 forward stock split pursuant to a stock dividend, resulting in the reporting person's ownership of 5,100 additional shares.
The exercise price reflects a 2-for-1 forward stock split effected by the Issuer on June 5, 2015.
The option vests in 48 equal monthly installments and will be fully vested and exercisable on May 14, 2017.
On June 5, 2015, the Issuer effected a 2-for-1 forward stock split, resulting in the reporting person's ownership of 20,000 additional options.